House Committee Passes ‘FIND Act,’ Which Would Change How Some Radiopharmaceuticals Are Reimbursed

Background: In 2023, the Centers for Medicare & Medicaid Services (CMS) sought feedback on its current packaging policy for radiopharmaceuticals. CMS specifically asked for input on the advisability of a separate payment for radiopharmaceuticals above a per-day cost threshold of $140 (or some other per-day threshold).

In comments submitted to CMS, ASNC emphasized the importance of fully understanding the implications of the proposed policy change on nuclear medicine ambulatory payment classifications (APCs) and potential cuts in reimbursement before moving forward with changes. (For background on how APCs work, view ASNC’s Health Policy 101 video “Ambulatory Payment Classifications and Your Reimbursement.”)

Now What? The next step for the FIND Act is consideration by the full House of Representatives. The bill currently has 41 cosponsors. It is important to note that CMS has the authority to change the current packaging policy without passage of the FIND Act; however, the House’s consideration of the bill could put pressure on CMS to act.